Skip to content

Phibro Animal Health PAHC Enterprise value

Enterprise value at other companies

Merck & Co. logo
Merck & Co.MRK
$341.11B+34.2%
Zoetis logo
ZoetisZTS
$57.95B-26.4%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$15.79B+73.1%
Neogen logo
NeogenNEOG
$3.08B+4.4%
Balchem logo
BalchemBCPC
$5.39B+0.1%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$5.33B+162%

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.27B+31.4%
P/E13.4×-17.1×
P/S0.9×0.0×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Calculated from Phibro Animal Health’s reported figures.

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phibro Animal Health's enterprise value?
Phibro Animal Health (PAHC) reported enterprise value of $2.22B in Q1 2026.
How has Phibro Animal Health's enterprise value changed year-over-year?
Phibro Animal Health's enterprise value increased by 167.4% year-over-year, from $830.04M to $2.22B.
What is the long-term trend for Phibro Animal Health's enterprise value?
Over 4 years (2021 to 2025), Phibro Animal Health's enterprise value has grown at a -3.8% compound annual growth rate (CAGR), from $1.16B to $995.1M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.